Concepta PLC (CPT) - Launch of myLotus app in China
20 February 2018 - 9:22PM
ADVFN NewsWire
Concepta plc
("Concepta"
or the "Company")
Launch of myLotus app in
China
Concepta plc (AIM: CPT), the UK healthcare
company and developer of a proprietary product targeted at the
mobile health market with a primary focus on women's fertility, is
pleased to announce that it has signed an agreement with Beijing
Jiayou Ltd, ("AppInChina") to manage the distribution of its new
myLotus app on Android systems throughout China.
The free app, which allows women to monitor and
track fertility, can be used either as an individual fertility
tracker or in conjunction with the myLotus monitor.
Through AppInChina, Concepta will focus on
distribution of the app through the top 5 Chinese Android app
stores, which between them have a market share of around 75.7%* of
the Android app market. This includes Tencent's Myapp, the
leading Chinese app store, which holds a 25.1%* market share of the
Android app distribution coverage in China.
In addition, the myLotus app is also currently
available on the Chinese iOS app store, which has a 13% smartphone
market share in China.
Erik Henau, CEO of Concepta commented: "The
myLotus app is an extremely useful resource for women trying to
conceive. Not only is it effective as a stand-alone resource, but
in conjunction with our myLotus meter, it is a powerful tool to
allow women with unexplained infertility to conceive naturally. It
enables women who are struggling to conceive to monitor their
ovulation cycle more effectively than standard home testing kits.
The combination of both the app and the myLotus meter will enhance
the consumer experience and the product proposition, as well as
increasing awareness of the product."
"As the only app with a direct link to
qualitative and quantitative results of a woman's personal hormone
levels, it provides women with a platform to build an accurate
conception diary, which will assist them and their partner during
the process of conception."
* Newzoo - "Top 10 android app stores" https://newzoo.com/insights/rankings/top-10-android-app-stores-china/
Enquiries:
The Company
Erik Henau
CEO
Tel: +44 (0) 1234 866601
SPARK Advisory Partners Limited
(Nomad)
Neil Baldwin / Mark Brady
Tel: +44 (0)20 368 3550
NOVUM Securities Limited (Broker)
Colin Rowbury
+44 (0) 20 7399 9400
Yellow Jersey (Financial PR)
Georgia Colkin / Joe Burgess / Katie
Bairsto
Tel: +44 (0) 776 932 5254
About Concepta Plc:
Concepta plc is an AIM-quoted pioneering UK
healthcare company that has developed a proprietary product,
myLotus, targeted at the personalised mobile health market with a
primary focus on unexplained infertility* in women.
myLotus is currently the only consumer product
which allows both quantitative and qualitative measurements of a
woman's personal LH and hCG* hormone levels in a home test,
facilitating higher conception rates and early diagnosis of issues
with fertility hormones. The proposition of myLotus is to help
women conceive naturally.
Concepta has made significant progress
recently, establishing agreements with a number of distributors in
China where myLotus has been given cFDA approval. Concepta is
initially targeting the traditional route to market in China
through Chinese hospitals and plans to add the direct-to-consumer
route in the near future.
The Company is also well on its way to
achieving CE-marking and commencing its direct-to-consumer launch
in the UK and Europe in H1 2018. The Company has identified a
significant global market opportunity, with revenue potential of
the Chinese and EU unexplained infertility market estimated to be
worth c.£600m per annum.
*Unexplained infertility refers to women that
have been unable to conceive after 6 months of trying. This highly
motivated target group of consumers won't typically be offered
medical intervention until 12 months of unsuccessfully trying, with
IVF not offered until two years. Research indicates couples start
to take positive action ahead of this time and there is little
medical support to help them do so.
About RNS Reach announcements
RNS Reach is an investor communication service
aimed at assisting listed and unlisted (including AIM quoted)
companies to distribute media only / non-regulatory news releases
such as marketing messages, corporate and product information into
the public domain. An RNS Regulatory announcement is required to be
notified under the AIM Rules for Companies.
Myhealthchecked (LSE:MHC)
Historical Stock Chart
From Apr 2024 to May 2024
Myhealthchecked (LSE:MHC)
Historical Stock Chart
From May 2023 to May 2024